These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21782150)

  • 1. Apoptosis induction and inhibition of hyperplasia formation by 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran in rat uterus.
    Chandra V; Fatima I; Saxena R; Kitchlu S; Sharma S; Hussain MK; Hajela K; Bajpai P; Dwivedi A
    Am J Obstet Gynecol; 2011 Oct; 205(4):362.e1-11. PubMed ID: 21782150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumorigenic action of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran: evidence for involvement of GPR30/EGFR signaling pathway.
    Chandra V; Fatima I; Saxena R; Hussain MK; Hajela K; Sankhwar P; Roy BG; Chandna S; Dwivedi A
    Gynecol Oncol; 2013 May; 129(2):433-42. PubMed ID: 23402905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of 2-(piperidinoethoxyphenyl)-3-(4-hydroxyphenyl)-2H-benzo(b)pyran (K-1) on human primary endometrial hyperplasial cells mediated via combined suppression of Wnt/β-catenin signaling and PI3K/Akt survival pathway.
    Chandra V; Fatima I; Manohar M; Popli P; Sirohi VK; Hussain MK; Hajela K; Sankhwar P; Dwivedi A
    Cell Death Dis; 2014 Aug; 5(8):e1380. PubMed ID: 25144715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3-Diaryl-2H-1-benzopyran derivatives interfere with classical and non-classical estrogen receptor signaling pathways, inhibit Akt activation and induce apoptosis in human endometrial cancer cells.
    Fatima I; Chandra V; Saxena R; Manohar M; Sanghani Y; Hajela K; Negi MP; Sankhwar PL; Jain SK; Dwivedi A
    Mol Cell Endocrinol; 2012 Jan; 348(1):198-210. PubMed ID: 21878365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-implantation effect of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran, a potent antiestrogenic agent in rats.
    Kharkwal G; Fatima I; Kitchlu S; Singh B; Hajela K; Dwivedi A
    Fertil Steril; 2011 Mar; 95(4):1322-7. PubMed ID: 20674906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of antiestrogenecity of compound CDRI-85/287: a new orally active nonsteroidal antiimplantation agent.
    Sreenivasulu S; Singh MM; Dwivedi A; Setty BS; Kamboj VP
    Indian J Exp Biol; 1992 Nov; 30(11):968-71. PubMed ID: 1293041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of AP-1 mediated estrogenic response by ormeloxifene in rat uterus.
    Awasthi S; Daverey A; Dwivedi A
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):208-14. PubMed ID: 17553677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
    Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus.
    Davis AM; Ellersieck MR; Grimm KM; Rosenfeld CS
    Mol Reprod Dev; 2006 Aug; 73(8):1034-44. PubMed ID: 16688783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Akt expression and phosphorylation by 17beta-estradiol in the rat uterus during estrous cycle.
    Dery MC; Leblanc V; Shooner C; Asselin E
    Reprod Biol Endocrinol; 2003 Jun; 1():47. PubMed ID: 12816542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene.
    Daverey A; Saxena R; Tewari S; Goel SK; Dwivedi A
    J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):93-101. PubMed ID: 19460436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
    Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
    Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDRI-85/287: studies on competition to estrogen binding sites in the immature rat uterus.
    Sreenivasulu S; Dwivedi A; Singh MM; Setty BS; Kamboj VP
    Indian J Exp Biol; 1992 Dec; 30(12):1115-7. PubMed ID: 1294475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SC79, the AKT Activator Protects Cerebral Ischemia in a Rat Model of Ischemia/Reperfusion Injury.
    Luan Q; Pan L; He D; Gong X; Zhou H
    Med Sci Monit; 2018 Aug; 24():5391-5397. PubMed ID: 30074018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite regulation of XIAP and Smac/DIABLO in the rat endometrium in response to 17beta-estradiol at estrus.
    Leblanc V; Dery MC; Shooner C; Asselin E
    Reprod Biol Endocrinol; 2003 Aug; 1():59. PubMed ID: 12967350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peroxisome proliferator activated receptors-alpha and -gamma agonists on estradiol-induced proliferation and hyperplasia formation in the mouse uterus.
    Gunin AG; Bitter AD; Demakov AB; Vasilieva EN; Suslonova NV
    J Endocrinol; 2004 Aug; 182(2):229-39. PubMed ID: 15283683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Oct; 303(1):196-203. PubMed ID: 12235251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation, mitosis orientation and morphogenetic changes in the uterus of mice following chronic treatment with both estrogen and glucocorticoid hormones.
    Gunin AG; Mashin IN; Zakharov DA
    J Endocrinol; 2001 Apr; 169(1):23-31. PubMed ID: 11250643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.